Clinical Trial Update: Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether nicotinamide riboside can protect against acetaminophen-induced liver injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acetaminophen-induced Liver Injury

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: University of South Alabama | Conditions: Drug Toxicity | Phase 1 | Status: COMPLETED